BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 17459079)

  • 1. Increased expression of Toll-like receptor 4 in peripheral blood leucocytes and serum levels of some cytokines in patients with ankylosing spondylitis.
    Yang ZX; Liang Y; Zhu Y; Li C; Zhang LZ; Zeng XM; Zhong RQ
    Clin Exp Immunol; 2007 Jul; 149(1):48-55. PubMed ID: 17459079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of tumor necrosis factor inhibitor on serum level of HLA-B27 and PDCD-1 in patients with ankylosing spondylitis.
    Chen X; Zhou X; Li X; Tang J; Hu X; Wang J; Xu C
    Cell Biochem Biophys; 2014 Nov; 70(2):1453-7. PubMed ID: 25005770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relation of HLA-B27, tumor necrosis factor-α promoter gene polymorphisms, and T cell cytokine production in ankylosing spondylitis -- a comprehensive genotype-phenotype analysis from an observational cohort.
    Poddubnyy DA; Märker-Hermann E; Kaluza-Schilling W; Zeidler H; Braun J; Listing J; Sieper J; Rudwaleit M
    J Rheumatol; 2011 Nov; 38(11):2436-41. PubMed ID: 21885496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human leukocyte antigen-G in ankylosing spondylitis and the response after tumour necrosis factor-alpha blocker therapy.
    Chen CH; Liao HT; Chen HA; Liu CH; Liang TH; Wang CT; Tsai CY; Chou CT
    Rheumatology (Oxford); 2010 Feb; 49(2):264-70. PubMed ID: 20008091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA-B27 subtypes and tumor necrosis factor alpha promoter region polymorphism in Iranian patients with ankylosing spondylitis.
    Nicknam MH; Mahmoudi M; Amirzargar AA; Jamshidi AR; Rezaei N; Nikbin B
    Eur Cytokine Netw; 2009 Mar; 20(1):17-20. PubMed ID: 19318316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preliminary clinical measurement of the expression of TNF-related apoptosis inducing ligand in patients with ankylosing spondylitis.
    Zai-Xing Y; Yan L; Hao W; Ye Z; Chang L; Ren-Qian Z
    J Clin Lab Anal; 2008; 22(2):138-45. PubMed ID: 18348311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum concentration and mRNA expression in milk somatic cells of toll-like receptor 2, toll-like receptor 4, and cytokines in dairy cows following intramammary inoculation with Escherichia coli.
    Ma JL; Zhu YH; Zhang L; Zhuge ZY; Liu PQ; Yan XD; Gao HS; Wang JF
    J Dairy Sci; 2011 Dec; 94(12):5903-12. PubMed ID: 22118081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TLR4 mutations (Asp299Gly and Thr399Ile) are not associated with ankylosing spondylitis.
    Adam R; Sturrock RD; Gracie JA
    Ann Rheum Dis; 2006 Aug; 65(8):1099-101. PubMed ID: 16837493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of infliximab and etanercept, two types of anti-tumor necrosis factor-alpha inhibitor on serum level of matrix metalloproteinase 3 expression in patients with ankylosing spondylitis].
    Yang CH; Huang F; Deng XH; Zhang JL; Zhang LY; Guo JH; Liang DF; Wang LS; Zhang YM
    Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(35):2451-4. PubMed ID: 17156669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TNF-238A promoter polymorphism contributes to susceptibility to ankylosing spondylitis in HLA-B27 negative patients.
    González S; Torre-Alonso JC; Martínez-Borra J; Fernández Sánchez JA; López-Vazquez A; Rodríguez Pérez A; López-Larrea C
    J Rheumatol; 2001 Jun; 28(6):1288-93. PubMed ID: 11409121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythrocyte sedimentation rate, C-reactive protein level, and serum amyloid a protein for patient selection and monitoring of anti-tumor necrosis factor treatment in ankylosing spondylitis.
    de Vries MK; van Eijk IC; van der Horst-Bruinsma IE; Peters MJ; Nurmohamed MT; Dijkmans BA; Hazenberg BP; Wolbink GJ
    Arthritis Rheum; 2009 Nov; 61(11):1484-90. PubMed ID: 19877087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activated toll-like receptor 4 in monocytes is associated with heart failure after acute myocardial infarction.
    Satoh M; Shimoda Y; Maesawa C; Akatsu T; Ishikawa Y; Minami Y; Hiramori K; Nakamura M
    Int J Cardiol; 2006 May; 109(2):226-34. PubMed ID: 16051384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of different tumor necrosis factor alpha promoter allele frequencies with ankylosing spondylitis in HLA-B27 positive individuals.
    Höhler T; Schäper T; Schneider PM; Meyer zum Büschenfelde KH; Märker-Hermann E
    Arthritis Rheum; 1998 Aug; 41(8):1489-92. PubMed ID: 9704649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of HLA-B27 antigens on mononuclear leucocytes in ankylosing spondylitis.
    van der Gaag R; Luyendijk L; Linssen A; Kijlstra A
    Clin Exp Immunol; 1985 May; 60(2):311-5. PubMed ID: 3874023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic levels of the T cell regulatory cytokines IL-10 and IL-12 in Bechçet's disease; soluble TNFR-75 as a biological marker of disease activity.
    Turan B; Gallati H; Erdi H; Gürler A; Michel BA; Villiger PM
    J Rheumatol; 1997 Jan; 24(1):128-32. PubMed ID: 9002023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased Th17 and Th1 cells in the peripheral blood of patients with early non-radiographic axial spondyloarthritis: a marker of disease activity in HLA-B27⁺ patients.
    Bautista-Caro MB; Arroyo-Villa I; Castillo-Gallego C; de Miguel E; Peiteado D; Puig-Kröger A; Martín-Mola E; Miranda-Carús ME
    Rheumatology (Oxford); 2013 Feb; 52(2):352-62. PubMed ID: 23065314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preliminary study of high mobility group box chromosomal protein 1(HMGB1) in ankylosing spondylitis patients.
    Chen Y; Sun W; Li S; Ni J; Su Y; Wang C; Luo X; Tu W; Shen G; Gong F; Zheng F; Dong L
    Clin Exp Rheumatol; 2015; 33(2):187-94. PubMed ID: 25602579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role for IL-10 in inducing functional impairment of monocytes upon TLR4 ligation in patients with chronic HCV infections.
    Liu BS; Groothuismink ZM; Janssen HL; Boonstra A
    J Leukoc Biol; 2011 Jun; 89(6):981-8. PubMed ID: 21385948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppressors of cytokine signalling in ankylosing spondylitis and their associations with disease severity, acute-phase reactants and serum cytokines.
    Chen CH; Chen HA; Liao HT; Liu CH; Tsai CY; Chou CT
    Clin Exp Rheumatol; 2016; 34(1):100-5. PubMed ID: 26812031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteopontin might be involved in bone remodelling rather than in inflammation in ankylosing spondylitis.
    Choi ST; Kim JH; Kang EJ; Lee SW; Park MC; Park YB; Lee SK
    Rheumatology (Oxford); 2008 Dec; 47(12):1775-9. PubMed ID: 18854347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.